Common Equity: The sum of all common equity items.
Eli Lilly and Company (LLY) had Common Equity of $15.85B for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$12.73B |
|
$2.76B |
|
$2.22B |
|
$10.50B |
|
$9.03B |
|
$3.70B |
|
$-239.00M |
|
$3.46B |
|
$3.46B |
|
$2.76B |
|
$2.76B |
|
$2.76B |
|
$2.76B |
|
$3.70B |
|
$4.16B |
|
898.70M |
|
900.60M |
|
$3.07 |
|
$3.06 |
|
| Balance Sheet Financials | |
$41.26B |
|
$18.47B |
|
$48.13B |
|
$89.39B |
|
$30.07B |
|
$34.50B |
|
$43.47B |
|
$73.54B |
|
|
Common Equity |
$15.85B |
$4.06B |
|
$15.85B |
|
947.73M |
|
| Cash Flow Statement Financials | |
$1.67B |
|
$-3.35B |
|
$1.38B |
|
$3.27B |
|
$3.09B |
|
$-175.10M |
|
$153.70M |
|
$-1.35B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
0.69 |
|
2.43 |
|
82.53% |
|
29.03% |
|
29.03% |
|
-- |
|
27.15% |
|
21.68% |
|
$156.10M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.24 |
|
0.91 |
|
99.01 |
|
17.41% |
|
67.89% |
|
3.09% |
|
5.48% |
|
$16.72 |
|
$0.17 |
|
$1.85 |
|